Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 May;20(5):967-975.
doi: 10.1111/jch.13283. Epub 2018 Apr 23.

Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24-hour ambulatory blood pressure database

Affiliations
Observational Study

Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24-hour ambulatory blood pressure database

Vivianne Presta et al. J Clin Hypertens (Greenwich). 2018 May.

Abstract

We previously demonstrated lower diastolic blood pressure (BP) levels under statin therapy in adult individuals who consecutively underwent 24-hour ambulatory BP monitoring and compared their levels to untreated outpatients. Here we evaluated systolic/diastolic BP levels according to different statin types and dosages. 987 patients (47.5% female, age 66.0 ± 10.1 years, BMI 27.7 ± 4.6 kg/m2 , clinic BP 146.9 ± 19.4/86.1 ± 12.1 mm Hg, 24-hour BP 129.2 ± 14.4/74.9 ± 9.2 mm Hg) were stratified into 4 groups: 291 (29.5%) on simvastatin 10-80 mg/d, 341 (34.5%) on atorvastatin 10-80 mg/d, 187 (18.9%) on rosuvastatin 5-40 mg/d, and 168 (17.0%) on other statins. There were no significant BP differences among patients treated by various statin types and dosages, except in lower clinic (P = .007) and daytime (P = .013) diastolic BP in patients treated with simvastatin and atorvastatin compared to other statins. Favorable effects of statins on systolic/diastolic BP levels seem to be independent of types or dosages, thus suggesting a potential class effect of these drugs.

Keywords: ambulatory blood pressure monitoring; hypertension; nighttime blood pressure; statins.

PubMed Disclaimer

Conflict of interest statement

Authors have no conflicts of interest to disclose on the contents of the present manuscript.

Figures

Figure 1
Figure 1
24‐hour ambulatory (left) and nighttime (right) systolic (panel A) and diastolic BP (panel B) levels in patients under different statin types. BP, blood pressure; simva, simvastatin; atorva, atorvastatin; rosuva, rosuvastatin
Figure 2
Figure 2
24‐hour ambulatory (left) and nighttime (right) systolic (panel A) and diastolic BP (panel B) BP levels in patients under different statin dosages. BP, blood pressure

Similar articles

Cited by

References

    1. Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. J Hypertens. 2008;26:1477‐1486. - PubMed
    1. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta‐analysis. Lancet. 2016;387:957‐967. - PubMed
    1. O'Brien E, Parati G, Stergiou G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731‐1768. - PubMed
    1. Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359‐1366. - PubMed
    1. Izzo JL Jr, Chrysant SG, Kereiakes DJ, et al. 24‐hour efficacy and safety of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy. J Clin Hypertens (Greenwich). 2011;13:873‐880. - PMC - PubMed

Publication types

MeSH terms